IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group - Feuring-Buske, M.; Kneba, M.; Unterhalt, M.; Engert, A.; Gramatzki, M.; Hiller, E.; Trümper, L.; Brugger, W.; Ostermann, H.; Atzpodien, J.; Hallek, M.; Aulitzky, E.; et al. (Springer, 2000)
http://dx.doi.org/10.1007/s002770000163
Keywords: WW-YZ